Latest Market News

ASX Limited announces that CEO Helen Lofthouse will step down in May 2026, coinciding with the imminent go-live of the CHESS project’s first phase. The Board initiates a global search for new leadership to guide the next stage of transformation.

Elanor Investors Group has secured securityholder approval for a $125 million recapitalisation with Rockworth Capital Partners and the acquisition of Firmus Capital, marking a pivotal step in stabilising its balance sheet and positioning for growth.

Computershare has reported solid first-half results with earnings per share up 3.9%, prompting an upgrade to full-year guidance and a notable dividend increase.

Computershare Limited has announced a fully franked ordinary dividend of AUD 0.55 per share for the six months ending December 2025, accompanied by a Dividend Reinvestment Plan with no discount.

GreenX Metals has successfully completed a A$13.6 million placement while confirming Poland’s appeal against a Singapore court ruling, underscoring ongoing legal challenges alongside fresh capital.

CSL Limited announces the retirement of CEO Dr Paul McKenzie, with veteran executive Gordon Naylor appointed as interim CEO and Managing Director. The leadership change marks a new chapter for the biotech giant amid ongoing strategic transformation.

Alice Queen Limited has successfully raised an additional $280,000 from unrelated investors, increasing the size of its tranche two placement to fund key exploration projects and working capital.

The Agency Group Australia reports robust Q2 FY26 growth with a 41% jump in Gross Commission Income and expanding national footprint. The company is accelerating its push into East Coast markets while managing supply constraints in Western Australia.

EMC Gold has responded to an ASX price query following a sudden spike in its share price, confirming no undisclosed information exists and affirming compliance with continuous disclosure rules.

Ark Mines Limited has signed a pivotal Memorandum of Understanding to trial processing of monazite ore from its Sandy Mitchell Rare Earths Project, aiming to recover critical minerals including Thorium, Neodymium, and Praseodymium.

Island Pharmaceuticals has confirmed the material significance of recent FDA feedback on its Galidesivir development pathway and addressed ASX queries on disclosure timing and capital raising activities.

Electro Optic Systems (EOS) has firmly rejected allegations from a recent Grizzly Research report, highlighting its strengthened financial position, significant contract wins, and strategic acquisition to bolster its defence technology portfolio.